GB9114950D0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
GB9114950D0
GB9114950D0 GB919114950A GB9114950A GB9114950D0 GB 9114950 D0 GB9114950 D0 GB 9114950D0 GB 919114950 A GB919114950 A GB 919114950A GB 9114950 A GB9114950 A GB 9114950A GB 9114950 D0 GB9114950 D0 GB 9114950D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919114950A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB919114950A priority Critical patent/GB9114950D0/en
Publication of GB9114950D0 publication Critical patent/GB9114950D0/en
Priority to PCT/GB1992/001207 priority patent/WO1993000898A1/fr
Priority to JP5502080A priority patent/JPH06508844A/ja
Priority to EP92914294A priority patent/EP0593573A1/fr
Priority to AU22306/92A priority patent/AU2230692A/en
Pending legal-status Critical Current

Links

GB919114950A 1991-07-11 1991-07-11 Pharmaceutical formulation Pending GB9114950D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB919114950A GB9114950D0 (en) 1991-07-11 1991-07-11 Pharmaceutical formulation
PCT/GB1992/001207 WO1993000898A1 (fr) 1991-07-11 1992-07-03 Formulation pharmaceutique comprenant une beta-lactamine et de l'acide clavulanique ou un sel de celui-ci soluble dans l'eau
JP5502080A JPH06508844A (ja) 1991-07-11 1992-07-03 ベータ−ラクタム抗生物質およびクラブラン酸またはその水溶性塩の医薬製剤
EP92914294A EP0593573A1 (fr) 1991-07-11 1992-07-03 Formulation pharmaceutique comprenant une beta-lactamine et de l'acide clavulanique ou un sel de celui-ci soluble dans l'eau
AU22306/92A AU2230692A (en) 1991-07-11 1992-07-03 Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919114950A GB9114950D0 (en) 1991-07-11 1991-07-11 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
GB9114950D0 true GB9114950D0 (en) 1991-08-28

Family

ID=10698173

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919114950A Pending GB9114950D0 (en) 1991-07-11 1991-07-11 Pharmaceutical formulation

Country Status (5)

Country Link
EP (1) EP0593573A1 (fr)
JP (1) JPH06508844A (fr)
AU (1) AU2230692A (fr)
GB (1) GB9114950D0 (fr)
WO (1) WO1993000898A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1289084C (zh) 1995-09-07 2006-12-13 史密丝克莱恩比彻姆有限公司 药物制剂
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
DE19706978A1 (de) * 1997-02-21 1998-08-27 Ulrich Dr Posanski Kombinationspräparat für oral applizierbare Antibiotika
US20010016577A1 (en) * 1998-08-24 2001-08-23 Douglas Joseph Dobrozsi Oral mucoadhesive compositions containing gastrointestinal actives
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
WO2002030392A2 (fr) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Nouvelle formulation
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
KR101420446B1 (ko) 2005-09-22 2014-07-16 메이지 세이카 파루마 가부시키가이샤 메탈로-β-락타마제 저해제
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
EP2568959A2 (fr) 2010-05-14 2013-03-20 Mahmut Bilgic Formulations comprenant une céphalosporine et un acide clavulanique de troisième génération
WO2011142730A1 (fr) 2010-05-14 2011-11-17 Mahmut Bilgic Composition pharmaceutique comprenant la céfixime et un composé dérivé de l'acide clavulanique
EP2575777A1 (fr) 2010-06-03 2013-04-10 Mahmut Bilgic Formulation comprenant du cefpodoxime proxétil et de l'acide clavulanique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3266580D1 (en) * 1981-12-02 1985-10-31 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
GB9007945D0 (en) * 1990-04-07 1990-06-06 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
WO1993000898A1 (fr) 1993-01-21
JPH06508844A (ja) 1994-10-06
EP0593573A1 (fr) 1994-04-27
AU2230692A (en) 1993-02-11

Similar Documents

Publication Publication Date Title
IL102777A0 (en) Pharmaceutical combination formulation
ZA923272B (en) Pharmaceutical formulations
IL101679A0 (en) Pharmaceutical tablet formulation
AP9200356A0 (en) Pharmaceutical composition
GB9114950D0 (en) Pharmaceutical formulation
GB9103302D0 (en) Pharmaceutical formulations
ZA92729B (en) Pharmaceutical agent
SG49144A1 (en) Pharmaceutical formulation
GB9216061D0 (en) Pharmaceutical combination formulation
GB9112974D0 (en) Pharmaceutical formulation
GB9122115D0 (en) Pharmaceutical formulation
GB9122114D0 (en) Pharmaceutical formulation
GB9121798D0 (en) Pharmaceutical formulation
GB9116467D0 (en) Pharmaceutical formulation
GB9022280D0 (en) Pharmaceutical formulation
GB9019070D0 (en) Pharmaceutical formulation
GB9013312D0 (en) Pharmaceutical formulation
IE900901L (en) Pharmaceutical formulation
GB9006650D0 (en) Pharmaceutical formulation
IE901206L (en) Pharmaceutical formulation
GB9221694D0 (en) Pharmaceutical formulation
GB9212968D0 (en) Pharmaceutical formulation
GB9114621D0 (en) Pharmaceutical formulations
GB9103444D0 (en) Pharmaceutical formulations
GB9124803D0 (en) Pharmaceutical formulations